But current and former agency staff, as well as medical ethics experts, say recent cuts at the FDA are already making it more ...

And more health news stories you need to start your week.

Curay, the FDA’s acting top drug regulator, is stepping down from her post after serving at the agency for more than eight ...

Recent shifts within the U.S. FDA reflect an increasingly complex tension between scientific rigor and accelerating political ...

Jaqueline Corrigan-Curay, who serves as acting head of the FDA’s Center for Drug Evaluation and Research, will depart next ...